应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
MSD MSD能源债务基金
交易中 02-10 14:17:32 EST
7.82
+0.03
+0.32%
最高
7.83
最低
7.77
成交量
5.97万
今开
7.77
昨收
7.79
日振幅
0.77%
总市值
1.58亿
流通市值
1.58亿
总股本
2,022万
成交额
46.62万
换手率
0.30%
流通股本
2,020万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
科伦博泰生物－ＢExpect more important data release
招银国际 · 2025-08-21
科伦博泰生物－ＢExpect more important data release
翰森制药25年上半年业绩超预期，公司上调全年指引，全球化进程持续推进
招商证券(香港) · 2025-08-20
翰森制药25年上半年业绩超预期，公司上调全年指引，全球化进程持续推进
上半年20起大型药企与中国创新药公司交易！
创鉴汇 · 2025-07-16
上半年20起大型药企与中国创新药公司交易！
中国北方“首发”！这一平台，启动！
天津发布 · 2025-03-02
中国北方“首发”！这一平台，启动！
康乐卫士深陷亏损困境，未来如何破局？
新浪证券 · 2025-02-11
康乐卫士深陷亏损困境，未来如何破局？
药明生物与MSD International达成39亿港元资产交易协议
财中社 · 2025-01-06
药明生物与MSD International达成39亿港元资产交易协议
【药明生物(02269.HK)附属拟以5亿美元出售爱尔兰疫苗设施相关的资产】药明生物(02269.HK)发布公告，于2025年1月6日(交易时段后)，公司及药明海德爱尔兰(卖方)(公司间接全资附属公司)与MSD International(买方)订立协议，据此，按照协议的条款及条件，卖方已有条件同意出售及买方已有条件同意购买与爱尔兰疫苗设施相关的资产，总对价约为5亿美元。爱尔兰疫苗设施是卖方为买方生产商业疫苗产品，以满足买方的业务需求而设计及建造的专用设施。
金融界 · 2025-01-06
【药明生物(02269.HK)附属拟以5亿美元出售爱尔兰疫苗设施相关的资产】药明生物(02269.HK)发布公告，于2025年1月6日(交易时段后)，公司及药明海德爱尔兰(卖方)(公司间接全资附属公司)与MSD International(买方)订立协议，据此，按照协议的条款及条件，卖方已有条件同意出售及买方已有条件同意购买与爱尔兰疫苗设施相关的资产，总对价约为5亿美元。爱尔兰疫苗设施是卖方为买方生产商业疫苗产品，以满足买方的业务需求而设计及建造的专用设施。
自动驾驶上市竞速，高光下的生存博弈
蓝鲸财经 · 2024-11-01
自动驾驶上市竞速，高光下的生存博弈
智飞万泰沃森前三季度利润均腰斩，国产HPV疫苗还能怎么卷？
投资时间 · 2024-10-31
智飞万泰沃森前三季度利润均腰斩，国产HPV疫苗还能怎么卷？
公司概况
公司名称：
MSD能源债务基金
所属市场：
NYSE
上市日期：
--
主营业务：
Morgan Stanley Emerging Markets Debt Fund Inc于1993年5月6日在马里兰州注册成立，并根据1940年《投资公司法》（经修订）（"法案"）注册为非多元化封闭式管理投资公司。该基金的主要投资目标是通过主要投资于新兴国家政府和政府相关发行人的债务证券、为重组这些发行人的未偿债务而组织的实体的债务证券以及根据新兴国家法律组织的公司发行人的债务证券，创造高流动收入，并作为次要目标寻求资本增值。
发行价格：
--
{"stockData":{"symbol":"MSD","market":"US","secType":"STK","nameCN":"MSD能源债务基金","latestPrice":7.815,"timestamp":1770750643236,"preClose":7.79,"halted":0,"volume":59676,"delay":0,"changeRate":0.0032092426187420226,"floatShares":20199105,"shares":20221593,"eps":0.802112,"marketStatus":"交易中","change":0.025,"latestTime":"02-10 14:17:32 EST","open":7.77,"high":7.83,"low":7.77,"amount":466189.18650959997,"amplitude":0.007702,"askPrice":7.82,"askSize":404,"bidPrice":7.81,"bidSize":400,"shortable":3,"etf":1,"ttmEps":0.802112,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770757200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":7.79,"aum":0,"dividendRate":0.093385,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":7.79,"preClose":7.79,"latestTime":"08:00 EST","volume":62,"amount":482.98,"timestamp":1770728458397,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":7.79,"preClose":7.79,"latestTime":"16:10 EST","volume":34,"amount":264.86,"timestamp":1770671404388,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.857317},"requestUrl":"/m/hq/s/MSD/wiki","defaultTab":"wiki","newsList":[{"id":"2561941349","title":"科伦博泰生物－ＢExpect more important data release","url":"https://stock-news.laohu8.com/highlight/detail?id=2561941349","media":"招银国际","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561941349?lang=zh_cn&edition=full","pubTime":"2025-08-21 10:15","pubTimestamp":1755742543,"startTime":"0","endTime":"0","summary":"管理层预计SKB264在2025年的销售额将达到8亿至10亿元。估值敏感性分析显示，目标价对WACC和终端增长率的变化较为敏感。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250821103044a495200b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250821103044a495200b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4097","MSD"],"gpt_icon":0},{"id":"2561883574","title":"翰森制药25年上半年业绩超预期，公司上调全年指引，全球化进程持续推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2561883574","media":"招商证券(香港)","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561883574?lang=zh_cn&edition=full","pubTime":"2025-08-20 14:14","pubTimestamp":1755670489,"startTime":"0","endTime":"0","summary":"2025上半年收入超出低双位数增长指引，得益于创新产品组合和BD合作。管理层此前预测肿瘤产品在25年上半年实现21.3%的增长，我们估算其销售额达到37亿元人民币，其中大部分来自阿美乐。管理层维持2025财年阿美乐营收目标为60亿元人民币，并指引其峰值销售额可达80亿元人民币。2030年前推出20余款创新药，覆盖逾40项适应症研发是一项长期投入，公司在25年上半年将其19.4%的收入投入研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820143040a493591f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820143040a493591f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","MSD","CNS"],"gpt_icon":0},{"id":"2551141731","title":"上半年20起大型药企与中国创新药公司交易！","url":"https://stock-news.laohu8.com/highlight/detail?id=2551141731","media":"创鉴汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551141731?lang=zh_cn&edition=full","pubTime":"2025-07-16 17:08","pubTimestamp":1752656931,"startTime":"0","endTime":"0","summary":"2025年上半年，大型药企与中国创新药公司之间的交易活动活跃度提高，反映出中国在全球创新药领域的快速崛起和强大吸引力。根据创鉴汇不完全统计，上半年中国创新药企与大型药企共达成20笔交易，披露的交易潜在总金额近300亿美元，其中单笔最高达60.5亿美元，显示出大型药企对中国创新药的高度信心。协议包括首付款8000万美元，潜在交易总额20.1亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716174021a44e69e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716174021a44e69e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BLSP4452.SGD","LU0456855351.SGD","LU0234572021.USD","LU2417539215.USD","LU0225284248.USD","LU2236285917.USD","SG9999002232.USD","BK4550","BK4581","LU0985481810.HKD","LU0109394709.USD","LU0868494617.USD","AZN","MRK","BK4080","LU0321505868.SGD","IE0002270589.USD","SG9999002224.SGD","SG9999011175.SGD","IE00B19Z3581.USD","MSD","PFE","LU0170899867.USD","LU1894683348.USD","01093","LU2462157665.USD","BK4585","SGXZ57979304.SGD","LU0321505439.SGD","LU1883839398.USD","BK4534","SG9999003800.SGD","BK4592","SG9999001176.SGD","LU1066051498.USD","ADC","IE00BLSP4239.USD","BK4588","LU0306807586.USD","03692","LU0889565916.HKD","LU0122379950.USD","SG9999001176.USD","IE00B19Z3B42.SGD","LU0306806265.USD","IE00BBT3K403.USD","LU2456880835.USD","ORR","01530","LU1894683264.USD","BK4599","BK4007","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"2516599721","title":"中国北方“首发”！这一平台，启动！","url":"https://stock-news.laohu8.com/highlight/detail?id=2516599721","media":"天津发布","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516599721?lang=zh_cn&edition=full","pubTime":"2025-03-02 12:24","pubTimestamp":1740889440,"startTime":"0","endTime":"0","summary":"转自：天津发布3月1日，中国北方首家数字游民国际人才港——京津冀数字游民国际人才港暨泰达“超级个体”首发活动在中国天津人力资源服务产业园成功举行。作为中国北方“首发”的数字游民国际港，此次启动标志着京津冀协同发展在数字经济领域迈出了重要一步，为全球数字游民搭建起了一个全新的发展平台。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-03-02/doc-inenfvxn7821580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MSD"],"gpt_icon":0},{"id":"2510184606","title":"康乐卫士深陷亏损困境，未来如何破局？","url":"https://stock-news.laohu8.com/highlight/detail?id=2510184606","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510184606?lang=zh_cn&edition=full","pubTime":"2025-02-11 09:44","pubTimestamp":1739238240,"startTime":"0","endTime":"0","summary":" 近期，北京康乐卫士生物技术股份有限公司发布2024年度业绩预告，预计全年亏损3.16亿元至3.86亿元，相较于2023年净亏损3.01亿元，亏损幅度有所扩大，增幅在5.05%至28.40%之间。 作为一家专注于疫苗研发的生物科技企业，康乐卫士一直处于持续亏损状态，尚无产品上市销售。本文将从财务状况、研发进度、市场竞争、管理层变动等多个维度分析康乐卫士当前的困境与未来的不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-02-11/doc-inekanhk2853412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603392","BK4588","BK4532","BK0239","LU1829250122.USD","BK4585","GSK","GSK.UK","MSD","BK4007"],"gpt_icon":0},{"id":"2501233116","title":"药明生物与MSD International达成39亿港元资产交易协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2501233116","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501233116?lang=zh_cn&edition=full","pubTime":"2025-01-06 20:05","pubTimestamp":1736165134,"startTime":"0","endTime":"0","summary":"财中社1月6日电药明生物（02269）发布公告，宣布公司及药明海德爱尔兰（公司间接全资附属公司）与MSDInternational达成资产交易协议，涉及与爱尔兰疫苗设施相关的资产，总对价约为5亿美元（约39亿港元）。该设施为买方生产商业疫苗产品而设计及建造，交易将于2025年上半年交割，需满足若干先决条件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202501063288791611.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0588546209.SGD","LU1242518857.USD","02269","LU0516423174.USD","LU1242518931.SGD","BK1610","LU0856984785.SGD","LU0326950275.SGD","LU0417516902.SGD","LU1794554557.SGD","LU0307460666.USD","LU0516422440.USD","LU0823426308.USD","LU1720050803.USD","LU0348825331.USD","LU0140636845.USD","LU0417516738.SGD","LU1880383366.USD","LU0456846285.SGD","LU0516423091.SGD","LU0320764599.SGD","LU0456827905.SGD","BK1141","BK1521","LU0327786744.USD","SG9999002562.SGD","LU0819121731.USD","LU0823426480.USD","LU0359202008.SGD","MSD","LU0516422952.EUR","LU0572944931.SGD","LU0039217434.USD","LU2039709279.SGD","LU0181495838.USD","IE00B0JY6N72.USD","LU0359201612.USD","LU0348735423.USD","BK1576","LU0979878070.USD","BK1589","SG9999002463.SGD","LU0516422366.SGD","LU0708995583.HKD","LU0051755006.USD","LU0052750758.USD","LU1688375341.USD","LU0043850808.USD"],"gpt_icon":0},{"id":"2501238833","title":"【药明生物(02269.HK)附属拟以5亿美元出售爱尔兰疫苗设施相关的资产】药明生物(02269.HK)发布公告，于2025年1月6日(交易时段后)，公司及药明海德爱尔兰(卖方)(公司间接全资附属公司)与MSD International(买方)订立协议，据此，按照协议的条款及条件，卖方已有条件同意出售及买方已有条件同意购买与爱尔兰疫苗设施相关的资产，总对价约为5亿美元。爱尔兰疫苗设施是卖方为买方生产商业疫苗产品，以满足买方的业务需求而设计及建造的专用设施。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501238833","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501238833?lang=zh_cn&edition=full","pubTime":"2025-01-06 19:53","pubTimestamp":1736164439,"startTime":"0","endTime":"0","summary":"药明生物(02269.HK)发布公告，于2025年1月6日(交易时段后)，公司及药明海德爱尔兰(卖方)(公司间接全资附属公司)与MSD International(买方)订立协议，据此，按照协议的条款及条件，卖方已有条件同意出售及买方已有条件同意购买与爱尔兰疫苗设施相关的资产，总对价约为5亿美元。爱尔兰疫苗设施是卖方为买方生产商业疫苗产品，以满足买方的业务需求而设计及建造的专用设施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/06195347168659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0979878070.USD","LU0348735423.USD","BK1141","LU0307460666.USD","LU1880383366.USD","LU0052750758.USD","LU0327786744.USD","LU0572944931.SGD","LU0181495838.USD","LU0051755006.USD","BK1576","02269","LU0516422952.EUR","LU1720050803.USD","LU0326950275.SGD","LU0456846285.SGD","LU0417516738.SGD","LU0359202008.SGD","159646","LU1242518931.SGD","LU0516422440.USD","LU0140636845.USD","SG9999002562.SGD","BK1521","MSD","BK1589","LU0320764599.SGD","LU0456827905.SGD","LU0823426480.USD","LU1794554557.SGD","LU0516423174.USD","BK1610","LU0516423091.SGD","LU0856984785.SGD","SG9999002463.SGD","IE00B0JY6N72.USD","LU1242518857.USD","LU0039217434.USD","LU0359201612.USD","LU0708995583.HKD","LU0417516902.SGD","LU0516422366.SGD","LU0823426308.USD","LU0588546209.SGD","LU2039709279.SGD","LU0348825331.USD","LU0819121731.USD","LU1688375341.USD","LU0043850808.USD"],"gpt_icon":0},{"id":"2480502018","title":"自动驾驶上市竞速，高光下的生存博弈","url":"https://stock-news.laohu8.com/highlight/detail?id=2480502018","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480502018?lang=zh_cn&edition=full","pubTime":"2024-11-01 15:30","pubTimestamp":1730446227,"startTime":"0","endTime":"0","summary":"最近，国内自动驾驶企业都在股市上攻城拔地，争创各领域的“第一股”。再加上之前已经登陆资本市场的禾赛科技、速腾聚创、知行科技、黑芝麻智能，不完全统计，近两年来已有超过十余家自动驾驶企业启动上市或已成功上市。从今年来看，Robotaxi正展现出其在自动驾驶领域的商业化前景。今年无疑是自动驾驶企业登陆资本市场的“大年”。10月24日，地平线在港交所挂牌上市，拿下了“中国自动驾驶第一股”，并成为港股年内最大规模科技IPO。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/243597","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["MSD"],"gpt_icon":0},{"id":"2479781877","title":"智飞万泰沃森前三季度利润均腰斩，国产HPV疫苗还能怎么卷？","url":"https://stock-news.laohu8.com/highlight/detail?id=2479781877","media":"投资时间","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479781877?lang=zh_cn&edition=full","pubTime":"2024-10-31 15:10","pubTimestamp":1730358635,"startTime":"0","endTime":"0","summary":"智飞生物、万泰生物、沃森生物三家国内主要HPV疫苗销售企业，三季报主要业绩指标均表现为同比下滑标点财经、投资时间网研究员 卓玛你知道九价HPV（人乳头瘤病毒）疫苗吗？该疫苗美国获批至今不过十年，国内获批至今仅有六年，但进口的默沙东九价HPV疫苗已不再一针难求。更有甚者，国产的二价疫苗早已在政府集采中身陷价格战...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OvrH1Xa33Zh5DOXzShQ7irRrO1OxUPSQyVOPqmlG3y9xYAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OvrH1Xa33Zh5DOXzShQ7irRrO1OxUPSQyVOPqmlG3y9xYAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241031A05R0N00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241031A05R0N00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["IE00BSNM7G36.USD","LU0266013472.USD","LU0070302665.USD","09633","IE0002141913.USD","LU0985320562.USD","LU1116320901.HKD","LU0861579265.USD","MSD","BK4007","BK1161","LU0203345920.USD","BK4585","LU1066053197.SGD","BK4534","IE00B1BXHZ80.USD","LU0965509010.AUD","LU1917777945.USD","02179","IE00BLSP4452.SGD","IE00BBT3K403.USD","LU1057294990.SGD","LU0238689110.USD","LU0289739699.SGD","LU1116320737.USD","LU1585245621.USD","LU0122379950.USD","BK1589","LU0265550359.USD","LU0320765489.SGD","IE00BJJMRZ35.SGD","BK4559","LU1037948541.HKD","LU1037948897.HKD","MRK","BK4516","IE00BJT1NW94.SGD","LU1093756168.USD","LU1066051225.USD","LU1934455863.HKD","LU0965509283.SGD","LU1061106388.HKD","LU1093756325.SGD","BK4588","LU0965508806.USD","LU1066051498.USD","BK4550","LU1023059063.AUD","LU0058720904.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.morganstanley.com/im","stockEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.0485},{"period":"3month","weight":0.0657},{"period":"6month","weight":0.0456},{"period":"1year","weight":-0.0406},{"period":"ytd","weight":0.0541}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Morgan Stanley Emerging Markets Debt Fund Inc于1993年5月6日在马里兰州注册成立，并根据1940年《投资公司法》（经修订）（\"法案\"）注册为非多元化封闭式管理投资公司。该基金的主要投资目标是通过主要投资于新兴国家政府和政府相关发行人的债务证券、为重组这些发行人的未偿债务而组织的实体的债务证券以及根据新兴国家法律组织的公司发行人的债务证券，创造高流动收入，并作为次要目标寻求资本增值。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.015437},{"month":2,"riseRate":0.575758,"avgChangeRate":-0.007608},{"month":3,"riseRate":0.375,"avgChangeRate":-0.015923},{"month":4,"riseRate":0.59375,"avgChangeRate":0.004408},{"month":5,"riseRate":0.65625,"avgChangeRate":0.008522},{"month":6,"riseRate":0.40625,"avgChangeRate":-0.021408},{"month":7,"riseRate":0.65625,"avgChangeRate":0.012121},{"month":8,"riseRate":0.666667,"avgChangeRate":0.000253},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.01861},{"month":10,"riseRate":0.545455,"avgChangeRate":-0.000297},{"month":11,"riseRate":0.606061,"avgChangeRate":0.01823},{"month":12,"riseRate":0.515152,"avgChangeRate":0.003462}],"exchange":"NYSE","name":"MSD能源债务基金","nameEN":"MS Emerging Markets Debt Fund"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MSD能源债务基金(MSD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MSD能源债务基金(MSD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MSD能源债务基金,MSD,MSD能源债务基金股票,MSD能源债务基金股票老虎,MSD能源债务基金股票老虎国际,MSD能源债务基金行情,MSD能源债务基金股票行情,MSD能源债务基金股价,MSD能源债务基金股市,MSD能源债务基金股票价格,MSD能源债务基金股票交易,MSD能源债务基金股票购买,MSD能源债务基金股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MSD能源债务基金(MSD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MSD能源债务基金(MSD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}